Quarterly report pursuant to Section 13 or 15(d)

Transactions with BioXcel (Details)

v3.20.1
Transactions with BioXcel (Details)
$ in Thousands
1 Months Ended 3 Months Ended
Apr. 05, 2018
USD ($)
Nov. 07, 2017
USD ($)
shares
Feb. 29, 2020
USD ($)
shares
Jul. 31, 2019
USD ($)
Apr. 30, 2019
USD ($)
Mar. 31, 2020
USD ($)
shares
Mar. 31, 2019
USD ($)
Dec. 31, 2019
shares
Transactions with BioXcel                
Common shares, issued | shares           20,182,382   18,087,382
Payments to repurchase shares     $ 9,024     $ 9,024    
Shares repurchased (in shares) | shares     300,000     300,000    
BioXcel Corporation | Asset contribution agreement                
Transactions with BioXcel                
Common shares, issued | shares   9,480,000            
Lump sum payment to parent   $ 5,000            
Period specified for payment   60 days            
Cumulative net sales   $ 50,000            
Payment to (received from) related party $ 1,000     $ 500 $ 500      
BioXcel Corporation | Collaborative services agreement                
Transactions with BioXcel                
Term of agreement   5 years            
BioXcel Corporation | Development milestones                
Transactions with BioXcel                
Potential milestone payments   $ 10,000            
BioXcel Corporation | Sales milestones                
Transactions with BioXcel                
Potential milestone payments   $ 30,000            
Maximum milestone (as as percent)   3            
BioXcel Corporation | Separation and Shared Services Agreement                
Transactions with BioXcel                
Service charges           $ 397 $ 293  
BioXcel Corporation | Payable upon milestones | Asset contribution agreement                
Transactions with BioXcel                
Lump sum payment to parent   $ 1,000            
BioXcel Corporation | Payable upon later 12 months IPO and first dosing for BXCL501 | Asset contribution agreement                
Transactions with BioXcel                
Lump sum payment to parent   $ 500            
Period specified for payment   12 months            
BioXcel Corporation | Payable upon later of 12 months of IPO and specified milestones | Asset contribution agreement                
Transactions with BioXcel                
Lump sum payment to parent   $ 500            
Period specified for payment   12 months